Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Multimorbidity, social determinants and intersectionality in chronic patients. Results from the EpiChron Cohort

  • Moreno Juste, Aida
  • Gimeno Miguel, Antonio
  • Poblador Plou, Beatriz
  • Calderón Larrañaga, Amaia
  • Cano del Pozo, Mabel
  • Forjaz, Maria João
  • Prados Torres, Alexandra
  • Gimeno Feliú, Luis A.
Background: Multimorbidity is influenced in an interconnected way, both in extent and nature, by the social determinants of health. We aimed at implementing an intersectional approach to analyse the association of multimorbidity with five important axes of social inequality (i.e. gender, age, ethnicity, residence area and socioeconomic class). Methods: We conducted a cross-sectional observational study of all individuals who presented with at least one chronic disease in 2019 (n = 1 086 948) from the EpiChron Cohort (Aragon, Spain). Applying intersectional analysis, the age-adjusted likelihood of multimorbidity was investigated across 36 intersectional strata defined by gender, ethnicity, residence area and socioeconomic class. We calculated odds ratios (OR) 95% confidence interval (CI) using high-income urban non-migrant men as the reference category. The area under the receiver operator characteristics curve (AUC) was calculated to evaluate the discriminatory accuracy of multimorbidity. Results: The prevalence of multimorbidity increased with age, female gender and low income. Young and middle-aged low-income individuals showed rates of multimorbidity equivalent to those of high-income people aged about 20 years older. The intersectional analysis showed that low-income migrant women living in urban areas for >15 years were particularly disadvantaged in terms of multimorbidity risk OR = 3.16 (95% CI = 2.79-3.57). Being a migrant was a protective factor for multimorbidity, and newly arrived migrants had lower multimorbidity rates than those with >15 years of stay in Aragon, and even non-migrants. Living in rural vs. urban areas was slightly protective against multimorbidity. All models had a large discriminatory accuracy (AUC = 0.7884-0.7895); the largest AUC was obtained for the model including all intersectional strata. Conclusions: Our intersectional approach uncovered the large differences in the prevalence of multimorbidity that arise due to the synergies between the different socioeconomic and demographic exposures, beyond their expected additive effects.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Drug repurposing in oncology: a systematic review of randomized controlled clinical trials

  • Ioakeim-Skoufa, Ignatios
  • Tobajas-Ramos, Natalia
  • Menditto, Enrica
  • Aza-Pascual-Salcedo, Mercedes
  • Gimeno-Miguel, Antonio
  • Orlando, Valentina
  • González-Rubio, Francisca
  • Fanlo-Villacampa, Ana
  • Lasala-Aza, Carmen
  • Ostasz, Ewelina
  • Vicente-Romero, Jorge
Quality pharmacological treatment can improve survival in many types of cancer. Drug repurposing offers advantages in comparison with traditional drug development procedures, reducing time and risk. This systematic review identified the most recent randomized controlled clinical trials that focus on drug repurposing in oncology. We found that only a few clinical trials were placebo-controlled or standard-of-care-alone-controlled. Metformin has been studied for potential use in various types of cancer, including prostate, lung, and pancreatic cancer. Other studies assessed the possible use of the antiparasitic agent mebendazole in colorectal cancer and of propranolol in multiple myeloma or, when combined with etodolac, in breast cancer. We were able to identify trials that study the potential use of known antineoplastics in other non-oncological conditions, such as imatinib for severe coronavirus disease in 2019 or a study protocol aiming to assess the possible repurposing of leuprolide for Alzheimer’s disease. Major limitations of these clinical trials were the small sample size, the high clinical heterogeneity of the participants regarding the stage of the neoplastic disease, and the lack of accounting for multimorbidity and other baseline clinical characteristics. Drug repurposing possibilities in oncology must be carefully examined with well-designed trials, considering factors that could influence prognosis.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Mental health and risk of death and hospitalization in COVID–19 patients. Results from a large-scale population-based study in Spain

  • Moreno-Juste, Aida
  • Poblador-Plou, Beatriz
  • Ortega-Larrodé, Cristina
  • Laguna-Berna, Clara
  • González-Rubio, Francisca
  • Aza-Pascual-Salcedo, Mercedes
  • Bliek-Bueno, Kevin
  • Padilla, María
  • de-la-Cámara, Concepción
  • Prados-Torres, Alexandra
  • Gimeno-Feliú, Luis A.
  • Gimeno-Miguel, Antonio
The COVID–19 pandemic has created unprecedented challenges for health care systems globally. This study aimed to explore the presence of mental illness in a Spanish cohort of COVID-19-infected population and to evaluate the association between the presence of specific mental health conditions and the risk of death and hospitalization. This is a retrospective cohort study including all individuals with confirmed infection by SARS-CoV-2 from the PRECOVID (Prediction in COVID–19) Study (Aragon, Spain). Mental health illness was defined as the presence of schizophrenia and other psychotic disorders, anxiety, cognitive disorders, depression and mood disorders, substance abuse, and personality and eating disorders. Multivariable logistic regression models were used to examine the likelihood of 30-day all-cause mortality and COVID–19 related hospitalization based on baseline demographic and clinical variables, including the presence of specific mental conditions, by gender. We included 144,957 individuals with confirmed COVID–19 from the PRECOVID Study (Aragon, Spain). The most frequent diagnosis in this cohort was anxiety. However, some differences were observed by sex: substance abuse, personality disorders and schizophrenia were more frequently diagnosed in men, while eating disorders, depression and mood, anxiety and cognitive disorders were more common among women. The presence of mental illness, specifically schizophrenia spectrum and cognitive disorders in men, and depression and mood disorders, substance abuse, anxiety and cognitive and personality disorders in women, increased the risk of mortality or hospitalization after COVID–19, in addition to other well-known risk factors such as age, morbidity and treatment burden. Identifying vulnerable patient profiles at risk of serious outcomes after COVID–19 based on their mental health status will be crucial to improve their access to the healthcare system and the establishment of public health prevention measures for future outbreaks.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Multimorbidity patterns and trajectories in young and middle-aged adults: a large-scale population-based cohort study

  • Ioakeim-Skoufa, Ignatios
  • González-Rubio, Francisca
  • Aza-Pascual-Salcedo, Mercedes
  • Laguna-Berna, Clara
  • Poblador-Plou, Beatriz
  • Vicente-Romero, Jorge
  • Coelho, Helena
  • Santos-Mejías, Alejandro
  • Prados-Torres, Alexandra
  • Moreno-Juste, Aida
  • Gimeno-Miguel, Antonio
Introduction: The presence of multiple chronic conditions, also referred to as multimorbidity, is a common finding in adults. Epidemiologic research can help identify groups of individuals with similar clinical profiles who could benefit from similar interventions. Many cross-sectional studies have revealed the existence of different multimorbidity patterns. Most of these studies were focused on the older population. However, multimorbidity patterns begin to form at a young age and can evolve over time following distinct multimorbidity trajectories with different impact on health. In this study, we aimed to identify multimorbidity patterns and trajectories in adults 18–65 years old. Methods: We conducted a retrospective longitudinal epidemiologic study in the EpiChron Cohort, which includes all inhabitants of Aragón (Spain) registered as users of the Spanish National Health System, linking, at the patient level, information from electronic health records from both primary and specialised care. We included all 293,923 patients 18–65 years old with multimorbidity in 2011. We used cluster analysis at baseline (2011) and in 2015 and 2019 to identify multimorbidity patterns at four and eight years of follow-up, and we then created alluvial plots to visualise multimorbidity trajectories. We performed age- and sex-adjusted logistic regression analysis to study the association of each pattern with four- and eight-year mortality. Results: We identified three multimorbidity patterns at baseline, named dyslipidaemia & endocrine-metabolic, hypertension & obesity, and unspecific. The hypertension & obesity pattern, found in one out of every four patients was associated with a higher likelihood of four- and eight-year mortality (age- and sex-adjusted odds ratio 1.11 and 1.16, respectively) compared to the unspecific pattern. Baseline patterns evolved into different patterns during the follow-up. Discussion: Well-known preventable cardiovascular risk factors were key elements in most patterns, highlighting the role of hypertension and obesity as risk factors for higher mortality. Two out of every three patients had a cardiovascular profile with chronic conditions like diabetes and obesity that are linked to low-grade systemic chronic inflammation. More studies are encouraged to better characterise the relatively large portion of the population with an unspecific disease pattern and to help design and implement effective and comprehensive strategies towards healthier ageing.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Intersectional analysis of social determinants of health and their association with mortality in patients with multimorbidity

  • Moreno-Juste, Aida
  • Laguna-Berna, Clara
  • Poblador-Plou, Beatriz
  • Calderón-Larrañaga, Amaia
  • Librero, Julián
  • Lozano-Hernández, Cristina
  • Santos-Mejías, Alejandro
  • Castillo-Jimena, Marcos
  • Gimeno-Miguel, Antonio
  • Gimeno-Feliú, Luis A
Background We aimed to analyse the association between social determinants of health (SDH) and mortality in patients with multimorbidity from an intersectional point of view. Methods We conducted a retrospective observational study in the EpiChron cohort (Aragon, Spain), including all patients with two or more chronic conditions in 2015, who were followed up until 2020, to analyse all-cause mortality. Logistic regressions models were performed to analyse the likelihood of mortality across 24 intersectional strata defined by gender, migration status/length of stay, residence area and socioeconomic class. The area under the receiver operator characteristics curve was estimated to evaluate the discriminatory accuracy of mortality. Results Nearly one in 10 people with multimorbidity died during the study period. The likelihood of mortality was higher in men, in people with lower annual gross income, and in those living in rural areas. The intersectional analysis showed that low-income migrant men with more than 15 years in Spain and living in rural settings had a 4.2 times higher risk of death than that observed in middle-high income, non-migrant, urban women (reference group). Women had a lower risk of mortality than men regardless of annual gross income, migration status and residence area. Migrants’ mortality risk varied depending on socioeconomic situation. All models had a large discriminatory accuracy, which increased across the intersectional analysis. Conclusions There is a clear association between SDH and mortality in patients with multimorbidity. The intersectional approach used in this study revealed some interactions among these determinants, illustrating the social disadvantage that underlies the need to implement policies to promote equitable health promotion.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Influence of social determinants of health on quality of life in patients with multimorbidity and polypharmacy

  • Ruiz-Baena, José María
  • Moreno-Juste, Aida
  • Poblador-Plou, Beatriz
  • Castillo-Jimena, Marcos
  • Calderón-Larrañaga, Amaia
  • Lozano-Hernández, Cristina
  • Gimeno-Miguel, Antonio
  • Gimeno-Feliú, Luis A.
  • Aza-Pascual-Salcedo, Mercedes
  • González-Rubio, Francisca
  • Pico-Soler, Victoria
  • Abad-Díez, José María
  • Bandrés-Liso, María Cristina
  • Clerencia-Sierra, Mercedes
  • Marta-Moreno, Javier
  • Poncel-Falcó, Antonio
  • Multipap-Group
Background: Multimorbidity is one of the biggest challenges faced by modern medicine, especially when managing older patients who are also often taking multiple medications. Multimorbidity is influenced by social determinants of health, giving rise to health inequalities in the population. Here, we sought to determine the influence of social determinants of health on quality of life in patients with multimorbidity and polypharmacy. Methods and materials: This cross-sectional observational study included 573 patients aged 65–74 with multimorbidity (≥3 diseases) and polypharmacy (≥5 drugs). Corresponding data was taken drawn from the Spanish MULTIPAP study, and included social and demographic variables, and data on health-related quality of life and overall self-perceived health status, assessed using the 5-level version of the EuroQol 5-dimensional questionnaire (EQ-5D-5L). Descriptive, bivariate and multivariate analyses with logistic regression models were performed. Results: Mean patient age was 69.7 years, 55.8% of patients were female, 59.7% belonged to low social classes (V, VI), a monthly income of €1051–€1850 predominated, and the median number of diseases in the same patient was 6. Factors associated with higher quality of life were (odds ratio, OR) male gender (OR = 1.599, p = 0.013), a higher educational level (OR = 1.991, p = 0.036), an absence of urban vulnerability (OR = 1.605, p = 0.017), and the presence of medium social support (OR = 1.689, p = 0.017). Having a higher number of diseases was associated with poorer quality of life (OR = 0.912, p = 0.017). Conclusions: Our findings describe associations between social determinants of health and quality of life in patients aged 65–74 years with multimorbidity and polypharmacy. More illnesses, female gender, a lower education level, urban vulnerability, and less social support are associated with poorer quality of life, underscoring the need for a biopsychosocial approach in patient care.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Multimorbidity in Patients with Chronic Liver Disease: A Population-Based Study in the EpiChron Cohort, Spain

  • Moreno-Juste, Aída
  • Poblador-Plou, Beatriz
  • Laguna-Berna, Clara
  • Cruces-Mateo, Belén
  • Lenotti, Elisa
  • Santos-Mejías, Alejandro
  • Gimeno-Feliú, Luis A.
  • Gimeno-Miguel, Antonio
Background/Objectives: Chronic liver disease (CLD) is highly relevant in clinical practice due to its increasing incidence and associated mortality. We aimed to exhaustively characterize the multimorbidity of patients with CLD. Methods: This is a retrospective observational study of patients aged 18 years and older with a diagnosis of CLD in 2015 in the EpiChron Cohort (Spain). We analyzed the prevalence of comorbidities according to sex and age, conducted a logistic regression analysis with CLD as the independent variable and each of the comorbidities as dependent variables to obtain odds ratios (OR) adjusted for age and sex, and performed an exploratory factor analysis to identify the presence of multimorbidity patterns. Results: A total of 6836 adults had a diagnosis of CLD (mean age 61.6 years; 62.5% women), with an average of 13 co-existing chronic conditions. Arterial hypertension, lipid metabolism disorders, diabetes, obesity, and musculoskeletal diseases were the most frequent diseases. From the list of 110 chronic conditions analyzed, 75 were systematically associated with CLD, including (OR, 95% confidence interval) chronic pancreatitis (41.2, 33.5–50.6) and inherited metabolic disorders (14.9, 11.8–18.8). Three multimorbidity patterns were identified in both men and women, including cardiovascular, metabolic-geriatric, and mental-substance use, with some differences by sex. Conclusions: Multimorbidity is the norm in patients with CLD. Our results reveal that a comprehensive and integral approach based on person-centered care, which should take into account their entire spectrum of multimorbidity, is necessary during the care of this type of patient in clinical practice.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Charting the Pathways of Cardiometabolic Multimorbidity: A Systematic Review of Clinical Trajectories

  • Ioakeim-Skoufa, Ignatios
  • Ledesma-Calvo, Rubén
  • Moreno-Juste, Aida
  • Roque, Fátima
  • Atkins, Kerry
  • Hernández-Rodríguez, Miguel Ángel
  • Aza-Pascual-Salcedo, Mercedes
  • González-Rubio, Francisca
  • Lasala-Aza, Carmen
  • Esteban-Jiménez, Óscar
  • Avedillo-Salas, Ana
  • Cebollada-Herrera, Celeste
  • Gimeno-Miguel, Antonio
  • Vicente-Romero, Jorge
Background: Managing multimorbidity is a major challenge for healthcare systems. Cardiometabolic multimorbidity (CMM) is highly prevalent and linked to increased disease burden, functional decline, and mortality. While most studies focus on cross-sectional analyses, longitudinal approaches are essential for understanding disease progression and identifying patient groups who may benefit from targeted interventions. Objectives: This systematic review synthesises evidence from longitudinal studies on the incidence and progression of CMM, exploring transitions between multimorbidity clusters and their clinical implications. Methods: A systematic search was conducted in MEDLINE and EMBASE following PRISMA guidelines. Studies were included if they employed longitudinal designs and clustering techniques to assess multimorbidity evolution. The quality of evidence was evaluated using the GRADE system. Results: Ten studies met the inclusion criteria. CMM occurs across all age groups and both sexes, showing the highest mortality and functional decline rates. Patients with CMM frequently develop additional cardiometabolic conditions or transition to related clusters. Many also experience neurodegenerative and mental health disorders. Individuals from respiratory multimorbidity clusters often transition to CMM. Moreover, CMM is more prevalent in lower socioeconomic populations. Conclusions: Understanding multimorbidity trajectories enables targeted preventive strategies. Identifying patients with predictable progression can help design adequate and effective interventions, reduce health disparities, and improve healthcare outcomes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Electronic Health Records: A Gateway to AI-Driven Multimorbidity Solutions—A Comprehensive Systematic Review

  • Ioakeim-Skoufa, Ignatios
  • Cebollada-Herrera, Celeste
  • Marín-Bárcena, Concepción
  • Roque, Vitor
  • Roque, Fátima
  • Atkins, Kerry
  • Hernández-Rodríguez, Miguel Ángel
  • Aza-Pascual-Salcedo, Mercedes
  • Fanlo-Villacampa, Ana
  • Coelho, Helena
  • Lasala-Aza, Carmen
  • Ledesma-Calvo, Rubén
  • Gimeno-Miguel, Antonio
  • Vicente-Romero, Jorge
Background/Objectives: Artificial intelligence (AI) plays an important role in real-world health research. It can address the complexities of chronic diseases and their associated negative outcomes. This systematic review aims to identify the applications of AI that utilize real-world health data for populations with multiple chronic conditions. Methods: A systematic search was performed in MEDLINE and EMBASE following PRISMA guidelines. Studies were included if they applied AI methods using data from electronic health records for patients with multimorbidity. Results: Forty-four studies met the inclusion criteria. The review revealed AI applications identifying disease clusters, predicting comorbidities, and estimating health outcomes such as mortality, adverse drug reactions, and hospital readmissions. Commonly used AI techniques included clustering methods, XGBoost, random forest, and neural networks. These methods helped identify risk factors, predict disease progression, and optimize treatment plans. Conclusions: This study emphasizes the increasing role of AI in understanding and managing multimorbidity. Integrating AI into healthcare systems can enhance resource allocation, improve care delivery efficiency, and support personalized treatment strategies. However, further research is needed to overcome existing limitations, particularly the lack of standardized performance metrics, which affects model comparability. Future research should adhere to commonly recommended evaluation practices to improve reproducibility and meta-analysis.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Early dynamics of multimorbidity in 17.4 million people in Spain: onset patterns and prognostic value

  • Ioakeim-Skoufa, Ignatios
  • Vicente-Romero, Jorge
  • González-Rubio, Francisca
  • Aza-Pascual-Salcedo, Mercedes
  • Laguna-Berna, Clara
  • Sempere-Verdú, Ermengol
  • Vicens-Caldentey, Caterina
  • Palop-Larrea, Vicente
  • Arroyo-Aniés, María Pilar
  • Esteban-Jiménez, Óscar
  • Orueta-Sánchez, Ramón
  • Barrio-Díez, Isabel
  • Marín-Murillo, Pilar
  • Pearson, Sallie-Anne
  • Gómez-Vaquero, Carmen
  • Gimeno-Miguel, Antonio
  • Hernández-Rodríguez, Miguel Ángel
Abstract Multimorbidity, the coexistence of two or more chronic diseases, has become a defining challenge for ageing societies. Yet evidence on when and how chronic diseases begin to cluster, and on the prognostic importance of this timing, remains limited. We used nationwide primary care electronic health records covering 17.4 million people in Spain to reconstruct the onset and progression of chronic disease over the life course. The first recorded diagnosis was used to trace temporal trajectories of multimorbidity by age and sex. We examined how the first condition, age at diagnosis, and time since that diagnosis were associated with advanced (≥3 diseases), multisystem (≥2 organ systems), and complex multimorbidity (≥3 organ systems), as well as premature mortality (<50 and <65 years) and outcomes related to polypharmacy and high-risk prescribing, using multivariable regression and gradient boosting models. By 2021, more than one in three Spaniards lived with a chronic condition, and over half of adults aged 45 years or older had multimorbidity. Among them, nearly 60% had complex multimorbidity. The time elapsed since the first diagnosis showed the closest link to further accumulation, followed by age at first diagnosis and current age. Later onset, particularly after the mid-50s, was associated with faster decline once disease emerged. The timing of the first chronic condition is a powerful but often overlooked prognostic marker. Public health strategies delaying onset and integrating early management could substantially reduce the long-term burden of multimorbidity in European populations.